FIELD: cellular biology.
SUBSTANCE: present invention relates to the field of cellular biology, in particular to a method for proliferation of human Vγ9Vδ2 T-cells and a cultural medium for their proliferation. For implementation of the specified method, first, a composition is cultivated, containing T-cells, using a cultural medium capable of stimulating T-cells, which contains a full RPMI-1640 cultural medium with 10% fetal calf serum, interleukin-2, and a phosphonic acid compound, namely zoledronic acid. Next, the second cultural medium is used for cultivation of stimulated T-cells, which contains a full RPMI-1640 cultural medium with 10% fatal calf serum, interleukin-2, interleukin-15, and vitamin C. At the same time, a concentration of interleukin-2 is 40-500 ng/ml, a concentration of interleukin-15 is 3.48-700 ng/ml, a concentration of vitamin C is 70 mcM – 300 mM, a concentration of phosphonic acid compounds is 50-500 mcM.
EFFECT: present invention allows for improvement of the efficiency of proliferation and purity of Vγ9Vδ2 T-cells; human Vγ9Vδ2 T-cell obtained by means of cultivation in this method has a stronger antiapoptotic capacity and a longer period of cell survival, and, in addition, a level of expression of its critical NKG2D killer molecules is higher, which allows it to have a stronger capacity of destruction of tumor cells.
5 cl, 8 dwg, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBODIES TO BTN3A AND THEIR USE IN THE TREATMENT OF CANCER OR INFECTIOUS DISEASES | 2019 |
|
RU2800726C2 |
COMBINED THERAPY WITH USE OF CLAUDIN 18,2 ANTIBODIES FOR CANCER TREATMENT | 2013 |
|
RU2662066C2 |
COMBINED THERAPY USING THE ANTIBODIES TO CLAUDIN 18.2 FOR TREATMENT OF CANCER | 2013 |
|
RU2665321C2 |
COMBINATION THERAPY USING ANTIBODIES TO CLAUDIN 18.2 FOR TREATMENT OF CANCER | 2013 |
|
RU2789478C2 |
METHOD FOR PRODUCTION OF NATURAL KILLER CELLS, AND COMPOSITION FOR CANCER TREATMENT | 2019 |
|
RU2780848C2 |
MAMMALIAN CELLS EXPRESSING CD40L LIGAND AND THEIR APPLICATION | 2012 |
|
RU2627597C2 |
BTN2-SPECIFIC ANTIBODIES AND USE THEREOF | 2020 |
|
RU2821703C2 |
IMMUNOCYTOKINES BASED ON IL-15 AND IL-R[ALPHA] SUSHI DOMAIN | 2012 |
|
RU2644671C2 |
METHOD FOR DETECTING OR RECOVERING/PRODUCING A CIRCULATING TUMOR CELL USING A CELL PROLIFERATION TECHNIQUE | 2016 |
|
RU2707083C1 |
COMPOSITIONS TO TREAT INFLAMMATORY BOWEL CONDITION | 2008 |
|
RU2495121C2 |
Authors
Dates
2023-03-03—Published
2019-02-19—Filed